CorMedix (CRMD) Inventory Average (2016 - 2025)
CorMedix (CRMD) reported Inventory Average of $29.3 million for Q4 2025, up 662.6% on a YoY basis from $3.8 million in Q4 2024, and up 85.84% sequentially from $15.8 million in Q3 2025.
CorMedix (CRMD) Inventory Average (2016 - 2025) Analysis & Trends
CorMedix (CRMD) has 9 years of Inventory Average data on file, last reported at $29.3 million in Q4 2025.
- For the quarter ending Q4 2025, Inventory Average rose 662.6% year-over-year to $29.3 million; the trailing twelve-month figure through Dec 2025 stood at $29.3 million (up 662.6% YoY), and the FY2025 full-year result was $15.4 million, up 877.79% from the prior year.
- Inventory Average advanced to $29.3 million in Q4 2025, from $15.8 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $29.3 million in Q4 2025 to a low of $994.5 in Q3 2022.
- A 4-year average of $4.4 million and a median of $1.7 million in 2024 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average tumbled 98.36% in 2022 and surged 662.6% in 2025, its largest moves.
- Tracing CRMD's Inventory Average over 4 years: stood at $25963.0 in 2021, then plunged by 96.17% to $994.5 in 2022, then jumped by 386450.78% to $3.8 million in 2024, then surged by 662.6% to $29.3 million in 2025.
- Business Quant data shows CRMD's Inventory Average at $29.3 million in Q4 2025, $15.8 million in Q3 2025, and $5.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 644.91 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CorMedix | 546.82 Mn | 391.62 Mn | 107.31 Mn | 29.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29.32 Mn |
| Sep 30, 2025 | 15.78 Mn |
| Jun 30, 2025 | 5.06 Mn |
| Mar 31, 2025 | 4.26 Mn |
| Dec 31, 2024 | 3.84 Mn |
| Sep 30, 2024 | 3.82 Mn |
| Jun 30, 2024 | 1.66 Mn |
| Mar 31, 2024 | 2.21 Mn |
| Sep 30, 2022 | 994.50 |
| Jun 30, 2022 | 2,167.00 |
| Mar 31, 2022 | 2,811.00 |
| Dec 31, 2021 | 25,963.00 |
| Sep 30, 2021 | 60,822.50 |
| Jun 30, 2021 | 78,899.00 |
| Mar 31, 2021 | 114,317.50 |
| Dec 31, 2020 | 172,135.00 |
| Sep 30, 2020 | 239,270.50 |
| Jun 30, 2020 | 286,371.50 |
| Mar 31, 2020 | 316,686.50 |
| Dec 31, 2019 | 359,765.00 |